defects as a possible cause for hypothyroidism found in adulthood.
Hypothyroidism is a heterogeneous disorder, and is likely reflecting the complexity of the hormone synthesis pathway. Earlier literature reported that mutations in several genes such as the sodium iodide symporter [1, 2], thyroglobulin [3, 4] , pendrin [5, 6] , dual oxidase 2 [7, 8] , dual oxidase maturation factor 1 [9] , dual oxidase maturation factor 2 [7, 9] , TPO [10, 11] are involved in the disruption of thyroid hormone biosynthesis. Among these genes, mutations of the TPO gene, which causes a total iodide organification defect (TIOD), was reported to be the most severe and common condition [12] .
They were also evaluated for BMI, goiter, ankle jerk relaxation, skin texture and blood pressure.
Hormone Assay
Quantitative sandwich immunoassay kit (Siemens, India) was used to assay serum TSH level. Serum FT4 concentrations and anti TPO antibody were determined by radioimmunoassay (RIA).
Urinary Iodine Assay
Urinary iodine content was measured by a modification of the traditional colorimetric method of Sandell and Kolthoff (1937) [18] . This was done using the Ammonium persulfate method as described by Pino et al. (1996) [19] .
Genomic DNA isolation, PCR (Polymerase Chain Reaction) and DNA sequencing
Peripheral blood samples were collected from the case and control individuals. Genomic DNA was isolated from the blood leucocytes by using QIAamp Blood Kit (QIAGEN, Hilden, Germany). The 17 exonic region of the TPO gene, including the splicing regions, were amplified by polymerase chain reaction (PCR). PCR was performed in a Thermocycler (Applied Biosystems, Model No. 9902) using specific primers (Supplementary Table 1) for all exons and exon-intron boundaries. The reaction mixture (25 μL) contained 40-100 ng of genomic DNA, 1.5 mM MgCl 2 , 100 µM of each dNTP, 0.4 µM of each primer and 0.5 U of Taq DNA polymerase (Applied Biosystems). Denaturation at 95°C for 30 seconds, annealing at 55-60 o C for 30 seconds, and extension at 72°C for 30 seconds x 44 cycles were performed. The PCR products were subjected to direct sequencing using a Taq Dye Deoxy Terminator sequencing kit (PE Applied Biosystems, City, USA) with an ABI Prism 377 DNA sequencer (PE Applied Biosystems).
Statistical methods
χ 2 and Fisher exact tests were used to test the allelic and genotypic associations of each SNP. HardyWeinberg equilibrium of each SNP in case and control individuals were also examined using a χ 2 test. Student t-test was used to calculate any statistically significant difference of continuous independent variables like age, TSH and FT4 within the control and patient groups. We analysed non-parametric variables by Mann-Whitney U test. All tests were done using TPO catalyzes the iodination and subsequent coupling of tyrosine residues in thyroglobulin, resulting in the synthesis of the thyroid hormones T4 and T3 [13] . The human TPO gene (GenBank Accesion # NT_033000) is located on chromosome 2p25 and spans approximately 150 Kb, containing 17 exons [14] . TPO is a membrane-bound glycoprotein (102 kDa), found as a dimer [15] . TPO mutations are typically inherited as autosomal recessive traits [16] .
In literature there are very limited number of well defined genetic studies for hypothyroidism in adulthood and also there is no prior report on TPO gene defects for the development of hypothyroidism in the Indian population, although this medical condition afflicts a significant number of Indians (occurring in as many as ~8% of the population) [17] . In our study, we conducted the first case control-based genetic screening of TPO gene from West Bengal, India.
materials and methods

Study subjects
We enrolled 200 consecutive newly diagnosed treatment naïve hypothyroid patients (cases) (ages 18-60 years) between January 2009 to February 2012 from the outpatient department (OPD) of Endocrinology, Institute of Post Graduate Medical Education & Research (IPGME & R), Kolkata. Clinical symptoms or history suggestive of goiter or congenital hypothyroidism were not found in the previous history and there was no clinical manifestation for developmental defects in any subject enrolled in the study. 200 sex and age matched normal individuals (controls) with no clinical evidence of hypothyroidism, normal values of FT4 and TSH and negative family history of the thyroid disorder were also enrolled from the same community. We selected cases and controls whose urinary iodine excretion levels were within the normal range (10-20 µg/dL) (WHO, UNICEF and ICCIDD, 2001). We measured the level of anti TPO antibody of both cases and control individuals. Anti TPO antibody positive samples were excluded from this study. All participants of this study have given written consent. The experimental protocol was approved by the institutional ethics committee of IPGMER, Kolkata.
Clinical information
Clinical information included complaints such as lethargy, cold intolerance, constipation, or weight gain.
TSH and FT4 levels
The average serum TSH level was 35.85 ± 21.61 µIU/mL in cases as compared to 2.21 ± 0.94 µIU/mL in controls (p= <0.0001). Similarly, serum FT4 level was 1.26 ± 0.25 ng/dL in controls as compared to 0.25 ± 0.11 ng/dL in cases (p= < 0.0001).
Urinary iodine
In our study samples we found that 192 (96%) cases and 195 (97.5%) control individuals displayed a Urinary iodine excrerion (UIE), which was in the range of optimal iodine nutrition (10-20 µg/dL) (WHO, UNICEF and ICCIDD, 2001).
Genetic analysis of TPO gene
Genetic analysis of TPO gene in both case and control, showed six single nucleotide changes, which include three synonymous (Ala576Ala: c.1728G>A: rs78406347 [21, 22] , Asp666Asp: c.1998C>T: rs1126797 [21] [22] [23] [24] [25] and Pro715Pro: c.2145C>T: rs732608 [21, 23] ), one nonsynonymous (Thr725Pro: c.2173A>C: rs732609 [21] [22] [23] ) and two changes in intronic region ( IVS9+42T>C: rs6715129 [26] and IVS11+20G>A: rs10189329 [26] ). In addition two novel deletions [IVS12+144_+148delGGGGC and IVS12+144_+153delGGGGCGGGGC] in Intron-12 were observed in 2 patients (Table 2) .
GraphPad InStat software (GraphPad InStat software, San Diego, CA). Odds ratio and 95% confidential intervals were also calculated using the same software. Linkage disequilibrium (LD) pattern of SNPs in TPO was analyzed using Haploview 4.2. A Bonferroni correction was applied for multiple testing. Power was estimated using Genetic Power Calculator [20] .
results
Study sample
Among case individuals, 14.5% were male and 85.5% female, for a sex ratio (male:female) of 1:5.9 ( the worldwide ratio is ~1:6) and in control individuals the ratio was 1:5.2 (16% male and 84% female). The mean age of case population was 35.24 ± 10.19 years and in controls 34.01 ± 11.20 years. The case and control individuals were thus balanced in terms of age and gender (Table 1) .
Case individuals exhibited varied clinical manifestations of hypothyroidism (Table 1) . About 46.5% of patients showed positive familial history. We found 21% patients having goiter in our study. The associated clinical manifestations of hypothyroidism were lethargy (59%), weight gain (48.0%) and constipation (51.5%). Anti TPO antibody levels were negative in all patients. The clinical presentation of the hypothyroidism in the subject with CC genotype was shown in Table 4 . There were significant differences between AA+AC and CC genotypes of rs732609 with regard to serum TSH level (p = 0.02) and FT4 level (p = 0.004) ( Table 4) .
discussion
The present study evaluates the potential association of TPO gene in patients with hypothyroidism in
Linkage disequilibrium pattern
Out of six SNPs observed in TPO gene, rs732608 (Pro715Pro) and rs732609 (Thr725Pro) were found to be in perfect linkage disequilibrium (LD; r 2 value 1), which was calculated using the Haploview program (Fig. 1) . Hence, out of the 6 SNPs, 5 (IVS9+42T>C, Ala576Ala, Asp666Asp, IVS11+20G>A and Thr725Pro) were selected for further study among case and control individuals.
After the Bonferroni correction for multiple comparisons a strong association was observed between the Thr725Pro (rs732609: A>C) and Asp666Asp (rs1126797: C>T) SNPs and hypothyroidism (Table  3) . Therefore, our results suggest that for rs732609 (Thr725Pro: c.2173A>C) C allele is the risk allele (p=0.01; Odds ratio = 1.45; 95% CI: 1.09-1.92) and CC genotype is a risk genotype (p=0.006; Odds ratio = 1.95; 95% CI: 1.20-3.15) (Table 3) . Our findings also suggest that T allele of rs1126797 (c.1998C>T: Asp666Asp) may be a protective allele (p= 0.006; Odds ratio = 0.67; 95% CI: 0.50-0.89 towards the development of hypothyroidism. The power was computed for all the SNPs, and the power ranged from 18.8% to 43.3% (Supplementary Table 2 ) of the six single nucleotide polymorphisms in TPO in case and control groups. The LD between the SNPs is measured as r 2 and shown in the diamond at the intersection of the diagonals from each SNP. r 2 = 0 is shown as white, 0 < r 2 <1 is shown in gray and r 2 = 1 is shown in black. sheet. Simultaneously threonine is the phosphorylation site of the protein which is important for the activation of the protein [30, 31] . Therefore, alterations of this amino acid may change the activity of TPO enzyme which ultimately may reduce the functional efficacy of the enzyme. Functional analysis of this SNP is not yet done, which should be investigated in our future studies. Our study also suggests that the risk of hypothyroidism decreases with the number of 666SAsp (T) allele in our study population. Interestingly, we did not detect any mutation in the coding region of TPO gene. It is possible that mutation in promoter region and unscreened intronic regions of TPO gene are the cause of hypothyroidism.
In addition we did not analyze other regulatory genes of thyroid hormone biosynthesis including the sodium symporter (NIS), pendrin (PDS), DUOX2 and thyroglobulin. This study is under powered, elucidation of these results with much larger sample size may help in better understanding of the role of TPO variants in hypothyroidism.
In summary, we conducted the first genetic screening of hypothyroidism in India and found association of rs732609 (Thr725Pro) and rs1126797 (Asp666Asp) with hypothyroidism. Our study tried to detect the genetic etiology of this disease which may further help us to categorize the risk for hypothyroidism. This study may help to develop a genetic screening protocol for hypothyroidism, specific for the Indian population.
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West Bengal, India. The major outcome of this study was centered on TPO gene polymorphisms may be an important cause of hypothyroidism in India.
There is a high burden of thyroid diseases in India even in the current state of iodine sufficiency. TPO being a key enzyme for thyroid hormone synthesis, TPO gene defect (especially non-synonymous cSNPs) can potentially lead to severe defects in thyroid hormone production, due to total iodide organification defects (TIOD) or partial iodide organification defects (PIOD). Screening and identification of mutations in the TPO gene of patients with evidence of TIOD and PIOD has been done by several groups in different countries of the world like Argentina [16] , Netherlands [12] , Japan [27] , Brazil [25] , Portugal [28] , and China [29] . Majority of the studies related to TPO gene defect was centered on congenital hypothyroidism but our study was based on hypothyroidism detected in adulthood as we tried to evaluate the other potential causes of this disease in this population besides autoimmunity and iodine deficiency.
The present investigation reports the clinical studies and genetic analyses on the TPO gene in West Bengal, India. In this study urinary iodine levels indicate that iodine deficiency is not a problem in our screened sample.
We have done our screening for TPO gene by direct sequencing of 400 individuals. Our study identified six different SNPs which were previously reported. We also identified two novel deletions (biallelic) in two patients (Patient ID 48: 10 bp deletion, JQ269601 and Patient ID 122: 5 bp, JQ269602). The results revealed that the C allele of Thr725Pro (rs732609) is a risk allele as well as C/C genotype is a risk genotype associated with hypothyroidism. The minor allele frequency (MAF) of Thr725Pro (C) in control group is 38%. According to 1000 genomes project, MAF of Thr725Pro in Chinese (CHB) is 38.7%, in Japanese (JPT) 50% and in European (CEU, TSI, FIN, GBR, IBS) 39%. Our result is very much similar to Chinese and European population. The change of Threonine (Thr) to Proline (Pro) of Thr725Pro may interrupt the secondary structure of TPO protein. Proline acts as a structural disruptor in the middle of regular secondary structure elements such as alpha helixes and beta 
